ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 103 filers reported holding ARATANA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,186,000 | +268.3% | 229,898 | +156.6% | 0.00% | – |
| Q1 2019 | $322,000 | +84.0% | 89,600 | +214.5% | 0.00% | – |
| Q4 2018 | $175,000 | -54.3% | 28,490 | -56.5% | 0.00% | – |
| Q3 2018 | $383,000 | -32.6% | 65,500 | -51.0% | 0.00% | – |
| Q2 2018 | $568,000 | +145.9% | 133,800 | +155.2% | 0.00% | – |
| Q1 2018 | $231,000 | +17.3% | 52,420 | +40.4% | 0.00% | – |
| Q4 2017 | $197,000 | -49.0% | 37,326 | -40.7% | 0.00% | – |
| Q3 2017 | $386,000 | -3.3% | 62,900 | +13.9% | 0.00% | – |
| Q2 2017 | $399,000 | -94.5% | 55,200 | -96.0% | 0.00% | -100.0% |
| Q1 2017 | $7,228,000 | +1056.5% | 1,363,811 | +1468.9% | 0.00% | – |
| Q4 2016 | $625,000 | +65.8% | 86,930 | +115.7% | 0.00% | – |
| Q3 2016 | $377,000 | +179.3% | 40,300 | +151.9% | 0.00% | – |
| Q3 2015 | $135,000 | – | 16,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Engaged Capital LLC | 3,487,149 | $21,376,000 | 3.96% |
| Broadfin Capital, LLC | 4,083,135 | $25,030,000 | 3.29% |
| MPM ASSET MANAGEMENT LLC | 250,000 | $1,533,000 | 1.30% |
| GENERAL AMERICAN INVESTORS CO INC | 1,599,365 | $9,804,000 | 1.03% |
| Grandeur Peak Global Advisors, LLC | 821,038 | $5,033,000 | 0.65% |
| CADENCE CAPITAL MANAGEMENT LLC | 307,294 | $1,884,000 | 0.19% |
| Redmond Asset Management, LLC | 60,176 | $369,000 | 0.18% |
| Alambic Investment Management, L.P. | 65,000 | $398,000 | 0.17% |
| MENTA CAPITAL LLC | 39,562 | $243,000 | 0.09% |
| Campbell & CO Investment Adviser LLC | 12,990 | $88,000 | 0.09% |